Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference17 articles.
1. Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios;Goryakin;PLoS One,2020
2. Comparative approaches to drug pricing;Kang;Annu Rev Public Health,2020
3. It's still the prices, stupid: why the US spends so much on health care, and a tribute to Uwe Reinhardt;Anderson;Health Aff,2019
4. Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis;Vokinger;Lancet Oncol,2020
5. Paying for prescription drugs in the new administration;Kesselheim;JAMA,2021
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of competition on reimbursement decisions for cancer drugs in China: an observational study;The Lancet Regional Health - Western Pacific;2024-09
2. Clinical benefit, reimbursement outcomes, and prices of FDA-approved cancer drugs reviewed through Project Orbis in the USA, Canada, England, and Scotland: a retrospective, comparative analysis;The Lancet Oncology;2024-08
3. Challenges of Incorporating Life Cycle Drug Pricing in Cost-Effectiveness Models: A Review of Methods and Modeling Suggestions;Value in Health;2024-07
4. Global representativeness and impact of funding sources in cost-effectiveness research on systemic therapies for advanced breast cancer: A systematic review;The Breast;2024-06
5. Time trends and regional variations in prices of anticancer medicines in China;Frontiers in Pharmacology;2024-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3